What are United Therapeutics's profit margins?

United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.

Where do United Therapeutics's ratios come from?

Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

United Therapeutics UTHR Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	86.6%-1.3pp	87.9%-0.7pp	88.6%-0.4pp	89%0.0pp	89%-0.2pp
Operating margin	45.3%-1.6pp	46.9%-0.8pp	47.7%+0.7pp	47%+0.2pp	46.9%-1.0pp
Net margin	40.6%-1.3pp	41.9%+1.3pp	40.7%+0.3pp	40.4%-0.1pp	40.4%-1.1pp
EBITDA margin	48.1%-1.5pp	49.6%-0.8pp	50.4%+0.7pp	49.6%+0.2pp	49.5%-0.9pp
Free cash flow margin	32.1%-0.6pp	32.7%-3.2pp	35.9%+1.1pp	34.8%-2.9pp	37.7%+0.1pp
Returns
Return on equity	20.3%+0.5pp	19.7%-0.3pp	20%+0.7pp	19.3%-0.6pp	19.9%+0.7pp
Return on assets	17.8%+0.3pp	17.5%-0.1pp	17.6%+0.6pp	17%0.0pp	17%+0.6pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Inventory turnover	2.5×+0.2×	2.3×0.0×	2.2×0.0×	2.2×-0.1×	2.3×0.0×
Liquidity
Current ratio	4.8×-1.8×	6.6×+0.2×	6.4×-0.9×	7.3×+1.8×	5.5×+0.2×
Quick ratio	4.5×-1.8×	6.3×+0.2×	6.1×-0.9×	6.9×+1.7×	5.2×+0.2×
Cash ratio	2.1×-0.6×	2.8×+0.3×	2.5×-0.6×	3×+0.4×	2.6×+0.3×
Leverage
Interest coverage	87.5×+11.0×	76.5×+15.1×	61.5×+15.3×	46.1×+6.8×	39.3×+7.2×
Per Share
Book value per share	$125.02-15.6%	$148.15+6.3%	$139.33-6.2%	$148.52+6.0%	$140.07+5.4%
Valuation
Market capitalization	$25.99B+23.9%	$20.98B+10.7%	$18.96B+45.0%	$13.08B-5.5%	$13.85B-12.1%
Price / earnings	20.2×+4.5×	15.7×+0.8×	14.9×+4.4×	10.5×-0.9×	11.4×-1.7×
Price / sales	8.2×+1.6×	6.6×+0.5×	6.1×+1.8×	4.2×-0.4×	4.6×-0.9×
Price / book	4.4×+1.4×	3×+0.1×	2.9×+1.1×	1.8×-0.2×	2×-0.4×
Free cash flow yield	3.9%-1.0pp	5%-1.0pp	5.9%-2.3pp	8.2%0.0pp	8.2%+1.3pp
Earnings yield	5%-1.4pp	6.4%-0.3pp	6.7%-2.8pp	9.5%+0.8pp	8.7%+1.2pp
PEG ratio	3.2×+1.8×	1.3×+0.3×	1×+0.4×	0.7×-0.1×	0.7×+0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about United Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are United Therapeutics's profit margins?: United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.
Where do United Therapeutics's ratios come from?: Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.